Tag: Paragraph IV certification
Jun, 23 2026
FDA's 180-Day Exclusivity: Benefits for First Generic Applicants
Explore how FDA's 180-day exclusivity rewards first generic applicants, the risks of forfeiture, and proposed reforms like the CGT model to improve patient access.